The Living Guidelines: UA/NSTEMI Recomendations for PCI Polling Results for CLASS I Guidelines

1. An early invasive PCI strategy is indicated for patients with UA/NSTEMI who have no serious comorbidity and who have coronary lesions amenable to PCI and any of the high-risk features listed in Section 3.3. (See UA/NSTEMI Guidelines 2007, Section 3.3 for specific recommendations and their Level of Evidence).
 * Class I

 CLASS I, Recommendation 1 for PCI in UA/NSTEMI should be: CLASS I CLASS IIa CLASS IIb CLASS III

2. Percutaneous coronary intervention (or CABG) is recommended for UA/NSTEMI patients with 1- or 2-vessel CAD with or without significant proximal left anterior descending CAD but with a large area of viable myocardium and high-risk criteria on noninvasive testing. (Level of Evidence: B)

 CLASS I, Recommendation 2 for PCI in UA/NSTEMI should be: CLASS I CLASS IIa CLASS IIb CLASS III

3. Percutaneous coronary intervention (or CABG) is recommended for UA/NSTEMI patients with multivessel coronary disease with suitable coronary anatomy, with normal LV function, and without diabetes mellitus. (Level of Evidence: A)

 CLASS I, Recommendation 3 for PCI in UA/NSTEMI should be: CLASS I CLASS IIa CLASS IIb CLASS III

4. An intravenous platelet GP IIb/IIIa inhibitor is generally recommended in UA/NSTEMI patients undergoing PCI. (Level of Evidence: A) See UA/NSTEMI Guidelines 2007, Section 3.2.3 and Figures 7, 8, and 9 for details on timing and dosing recommendations (see UA/NSTEMI Guidelines 2007, Table 13).

 CLASS I, Recommendation 4 for PCI in UA/NSTEMI should be: CLASS I CLASS IIa CLASS IIb CLASS III